Jim Cramer's Latest Post

Drug Stocks' Earnings Power Won't Go Away


Skip Raschke Intermediate Trade: XLNX

Technical Corner

Searching for Signals of a Bottom in Sprint

More Trading Strategies


Skip Raschke

 | Oct 7, 2015 | 8:00 AM EDT |
I prefer an out-of-the-money time or calendar call spread.

Eric Jackson

 | Oct 7, 2015 | 8:00 AM EDT |
DraftKings, FanDuel employees accused of insider trading. Would this ruin their IPOs?

James "Rev Shark" DePorre

 | Oct 7, 2015 | 7:44 AM EDT |
The best thing is to be an opportunist. 

Bob Byrne

 | Oct 7, 2015 | 7:00 AM EDT |
Healthy back-and-forth between bulls and sellers.

Antonia Oprita

 | Oct 7, 2015 | 5:30 AM EDT |
And four other things you need to know now.

Jim Cramer

 | Oct 7, 2015 | 5:23 AM EDT |
Before you sell them, ask yourself at what multiple you sell.

Helene Meisler

 | Oct 6, 2015 | 8:00 PM EDT |
But this one has been relentless so far.

James "Rev Shark" DePorre

 | Oct 6, 2015 | 4:10 PM EDT |
We're still stuck in a trading range.

Bruce Kamich

 | Oct 6, 2015 | 3:40 PM EDT |
The stock's longer-term price history points to something much more optimistic.

Roger Arnold

 | Oct 6, 2015 | 3:30 PM EDT |
Some want central bank to anticipate and deflate bubbles in capital markets.

Tim Melvin

 | Oct 6, 2015 | 3:00 PM EDT |
Potential takeover targets are popping up in the sector.

Bruce Kamich

 | Oct 6, 2015 | 2:30 PM EDT |
We're not sure when the stock will break out on the topside of its consolidation, but it could be soon. Longs should be...

Jim Cramer

 | Oct 6, 2015 | 2:04 PM EDT |
This move in health care takes your breath away.

Mike Norman

 | Oct 6, 2015 | 2:00 PM EDT |
Congress could eventually fail to raise the U.S. debt-ceiling.

Jared Woodard

 | Oct 6, 2015 | 1:51 PM EDT |
Take advantage of elevated option premiums to gain long exposure to biotech.

Upgrades & Downgrades

Oct 07, 2015 | 7:50 AM EDT
MS was upgraded from Sector Perform to Outperform, RBC Capital said. $39 price target. Wealth management can continue to drive growth a…
Oct 07, 2015 | 7:49 AM EDT
TSLA was initiated with a Sector Perform rating, RBC Capital said. $280 price target. Company faces execution risks. 
Oct 07, 2015 | 7:23 AM EDT
TSLA was downgraded from Outperform to Neutral, Robert Baird said. $282 price target. Model X ramp could take longer than expected.&nbs…
Oct 07, 2015 | 7:18 AM EDT
Shares of ADBE now seen reaching $65, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Neutral rat…
Oct 07, 2015 | 7:12 AM EDT
MJN was upgraded from Neutral to Buy, Nomura said. Valuation call, based on a $93 price target. 
An extreme in (bearish) sentiment was one of the reasons I endorsed the possibility of a b...
As we look toward some of the clues that help guide our market outlook, there are some sec...
I would pay attention to this one during the first hour of trading. I think the new CEO h...
Yum's getting ridiculous again because you have to wait for the call tomorrow and no one k...


News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.